Owen B. Wallace

Insider Reports History

Entity
Individual
Location
C/O Fulcrum Therapeutics, Inc., 26 Landsdowne Street, Cambridge, MA
Signature
/s/ Markus Warmuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Owen B. Wallace:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. Chief Scientific Officer Common Stock 5.27K $100K $19.00 Jan 2, 2024 Direct
Monte Rosa Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 119K Jan 2, 2024 Direct

Insider Reports Filed by Owen B. Wallace

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GLUE Monte Rosa Therapeutics, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 Chief Scientific Officer
GLUE Monte Rosa Therapeutics, Inc. Jan 3, 2023 1 $0 4 Jan 4, 2023 Chief Scientific Officer
GLUE Monte Rosa Therapeutics, Inc. Mar 1, 2022 1 $0 4 Mar 2, 2022 Chief Scientific Officer
GLUE Monte Rosa Therapeutics, Inc. Jun 23, 2021 0 $0 3 Jun 23, 2021 Chief Scientific Officer
GLUE Monte Rosa Therapeutics, Inc. Apr 12, 2021 2 $0 4 Jun 25, 2021 Chief Scientific Officer